Alström Syndrome with Acute Pancreatitis: A Case Report  by Wu, Wen-Chih et al.
Kaohsiung J Med Sci July 2003 • Vol 19 • No 7
W.C. Wu, S.C. Chen, C.Y. Dia, et al
358
Received: March 4, 2003 Accepted: April 22, 2003
Address correspondence and reprint requests to: Dr. Wan-Long
Chuang, Division of Hepatobiliary Medicine, Department
of Internal Medicine, Kaohsiung Medical University Hospital,
100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan.
E-mail: hb@www.kmu.edu.tw
Alström syndrome is a rare autosomal recessive
disease. Its major clinical features are cone-rod
dystrophy of the retinas, resulting in childhood
blindness, truncal obesity that manifests during
childhood, insulin-resistant diabetes mellitus,
progressive sensorineural hearing loss, and infantile-
or adolescent-onset dilated cardiomyopathy [1,2]. As
the patient suffered from visual and hearing
impairment, and problems associated with mental
retardation, further laboratory investigations to
determine if other organ systems were involved, an
understanding of the syndrome and a high index of
suspicion of other specific diseases were required.
Hyperinsulinemia and hypertriglyceridemia are fre-
quent in childhood. Children with dyslipidemia are at
risk of pancreatitis. We report the case of a 21-year-old
patient with Alström syndrome who suffered from
pancreatitis with obscure symptoms and signs.
CASE PRESENTATION
The patient was a 21-year-old woman with Alström
syndrome manifested by cone-rod dystrophy and
nystagmus, obesity, progressive sensorineural hearing
loss, diabetes mellitus, and hypertriglyceridemia.
Her parents were healthy but she had a younger
brother who also had Alström syndrome. She was
intermittently monitored at our hospital  and
glibenclamide and gemfibrozil had been prescribed.
She was sent to our hospital due to dull abdominal
pain. Physical examination showed pale conjunctivae
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We report the case of a 21-year-old female with Alström syndrome who also suffered from
acute pancreatitis of obscure manifestation. The patient had underlying cone-rod dystrophy
of the retinas, nystagmus, obesity, progressive sensorineural hearing impairment, diabetes
mellitus, and hypertriglyceridemia, compatible with the clinical diagnosis of Alström
syndrome. Serial examinations showed liver dysfunction and pancreatitis. In treating
a patient with poor communication (i.e. cone-rod dystrophy and hearing impairment)
suffering from acute illness, understanding the underlying disease and the potential for
pancreatitis with hypertriglyceridemia is necessary. It is also a challenge to treat a patient
with multiple system involvement. In conclusion, Alström syndrome is a disease of systemic
multi-organ involvement, and hepatic disease and pancreatitis, possibly due to dyslipidemia,
appear to be manifestations of Alström syndrome.
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and dull abdominal pain without rebounding pain.
Her blood glucose level was 439 mg/dL. Blood osmo-
larity was within the normal range. Arterial blood gas
analysis showed mild metabolic acidosis, with a base
excess –5.7 mEq/L. Routine urinalysis was negative
for ketones, proteinuria, and pyuria. Thus, diabetic
ketoacidosis and nonketotic hyperosmolar syndrome,
acute complications of diabetes mellitus, were eliminated.
A complete blood count showed a hematocrit of
37.4 g/dL, a white blood cell count of 34,380/+L, and
a normal platelet count. Blood urea nitrogen was
29 mg/dL, serum creatinine was 1.68 mg/dL, and
albumin level was normal. Alanine aminotransferase
(ALT) was 72 U/L (normal range, 10–40 U/L), aspartate
aminotransferase (AST) was 54 U/L (normal range,
10–35 U/L), a-glutamyltransferase (GGT) was
126 U/L (normal range, 0–48 U/L), lactate de-
hydrogenase was 434 U/L (normal range, 90–181 U/L),
and serum total calcium was normal. HbA1C was 11.0%
(normal range, < 6%). Triglycerides were 44.4 g/L (normal
range, 3.5–15.3 g/L), total cholesterol was 23.1 g/L
(normal range, 12.5–20.0 g/L), serum amylase was
323 U/L (normal range, 63–123 U/L), and serum lipase
was 1,530 U/L (normal range, 7–58 U/L).
The diagnosis of acute pancreatitis was suspected
and abdominal computed tomography (CT) was
performed (Figures 1 and 2), which showed swelling
of the pancreas and fluid accumulation in the right
perinephric area, hepatomegaly, splenomegaly, and
distension of the stomach. CT grading according to
Balthazar et al [3] was C. Ranson’s criteria score was
4. The patient was diagnosed with severe acute
pancreatitis.
Echocardiography was performed to assess the
possibility of dilated cardiomyopathy. The result was
negative. The follow-up CT revealed resolution of
fluid accumulation in the right perinephric area. A
liver biopsy was performed to determine the etiology
of hepatomegaly and showed mild hepatic fibrosis,
periportal inflammation, and fatty liver. After intensive
care, the patient’s condition stabilized and she was
discharged 20 days later.
DISCUSSION
We report a rare case of Alström syndrome compli-
cated by acute pancreatitis in a 21-year-old woman.
Alström syndrome is inherited in an autosomal reces-
sive manner. The diagnosis is based on clinical findings.
Molecular genetic testing for the ALMS1  gene
(chromosomal locus 2p13) is available on a research
basis only [4,5]. About 200 patients with Alström
syndrome are known worldwide [6]. The patient’s
diagnosis at the time of initial evaluation was Alström
Figure 1. Abdominal computed tomography with enhancement
showed swelling of the pancreas and fluid accumulation in the
right perinephric area, which are compatible with pancreatitis.
Figure 2. Abdominal computed tomography with enhancement
showed hepatomegaly, splenomegaly, and stomach distension.
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syndrome; a detailed history of the disease helps to
direct a detailed physical examination and selected
investigations. Long-term management depends on
the organ systems involved.
Abnormal liver function is common in early
childhood and can progress to hepatic failure in the
second to third decades of life and is common in
Alström syndrome. Measurement of plasma ALT, AST,
and GGT concentrations should be performed yearly.
The presence of high plasma ALT, AST, and GGT
concentrations is an indication for liver ultra-
sonography to evaluate possible hepatomegaly and
portal hypertension. Our patient showed hepatic
dysfunction, hepatomegaly, and splenomegaly.
Hepatic dysfunction appeared to be a manifestation of
Alström syndrome. Liver biopsies and postmortem
examinations have revealed varying degrees of hepatic
fibrosis, cirrhosis, and fatty liver [7,8]. The liver biopsy
of our patient showed similar results.
Serum triglyceride and cholesterol concentrations
should be measured annually or when the patient is ill
and/or dehydrated, because pancreatitis, precipitated
by hyperlipidemia, can be life-threatening. The pa-
tient’s initial cholesterol and triglyceride levels were
25.0–30.0 g/L and 30.0–35.0 g/L, respectively. Our
patient had hypertriglyceridemia, thus confirming the
diagnosis of pancreatitis, although the presenting
symptoms were obscure.
In conclusion, Alström syndrome is a systemic
disease of multiple organ systems. Hepatic disease
and pancreatitis, possibly due to dyslipidemia, appear
to be manifestations of Alström syndrome.
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